+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

H1N1 Vaccines - Global Strategic Business Report - Product Thumbnail Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • February 2026
  • 268 Pages
  • Global
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • February 2026
  • 182 Pages
  • Global
From
Conjugate Vaccines - Global Strategic Business Report - Product Thumbnail Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • February 2026
  • 271 Pages
  • Global
From
Shingles Vaccines - Global Strategic Business Report - Product Thumbnail Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • February 2026
  • 269 Pages
  • Global
From
Multivalent Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 278 Pages
  • Global
From
Mumps Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Mumps Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 288 Pages
  • Global
From
Chickenpox Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Chickenpox Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 374 Pages
  • Global
From
Toxoid Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 282 Pages
  • Global
From
Typhoid Fever Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Typhoid Fever Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Vaccine Technologies Market - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies Market - Global Strategic Business Report

  • Report
  • February 2026
  • 573 Pages
  • Global
From
From
Rotavirus Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Rotavirus Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 277 Pages
  • Global
From
Rubella Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Rubella Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 275 Pages
  • Global
From
Digital Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 274 Pages
  • Global
From
Polio Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Polio Vaccines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 277 Pages
  • Global
From
From
Clobetasol Propionate API Market - Global Forecast to 2030 - Product Thumbnail Image

Clobetasol Propionate API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Psoriatic Arthritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 452 Pages
  • Global
From
Sulphonamides Market - Product Thumbnail Image

Sulphonamides Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Loading Indicator